or Try an Advanced Search...

    Diabetic Nephropathy Stocks List

    Symbol Grade Name % Change
    BMY B Bristol-Myers Squibb Company 0.85
    MESO B Mesoblast Limited -1.98
    INCY C Incyte Corporation -1.32
    CYCN F Cyclerion Therapeutics, Inc. -11.72
    XRTX F XORTX Therapeutics Inc. 0.00
    ZVSA F ZyVersa Therapeutics, Inc. -0.87
    AMPE F Ampio Pharmaceuticals, Inc. 0.00
    View As Page of Charts
    Related Industries: Biotechnology Data Storage Drug Manufacturers - Major
    Related Stock Lists: Biopharmaceutical Kidney Disease Organ Systems Diabetes Heart Failure Inflammation Inflammatory Conditions Kidney Life Sciences Medicine Rheumatoid Arthritis S&P 500 Adult Stem Cell Alport Syndrome Antioxidant Atrial Fibrillation Autoimmune Disease Autosomal Dominant Polycystic Kidney Disease Back Pain Biopharmaceutical Products

    Related ETFs - A few ETFs which own one or more of the above listed Diabetic Nephropathy stocks.

    Symbol Grade Name Weight
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 9.51
    MEDX F Horizon Kinetics Medical ETF 6.23
    PPH D Market Vectors Pharmaceutical ETF 5.89
    MVAL B SHL Telemedicine Ltd VanEck Morningstar Wide Moat Value ETF 5.37
    IDNA D iShares Genomics Immunology and Healthcare ETF 5.36
    View all Diabetic Nephropathy ETFs...
    Compare ETFs
    Compare FTXH to MEDX Compare MEDX to PPH Compare PPH to MVAL

        Diabetic Nephropathy Stocks Recent News

        Date Stock Title
        Nov 21 INCY Biotech Stock Roundup: SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval & More
        Nov 21 BMY Major companies that are also popular short-selling stocks
        Nov 21 BMY Is Bristol Myers Squibb Stock a Buy?
        Nov 21 BMY Want Over $3,000 in Annual Dividends? Invest $20,000 in Each of These 3 Stocks
        Nov 19 INCY Equities Close Mostly Higher as Nvidia Jumps Ahead of Earnings; Wall Street Tracking Russia-Ukraine Conflict
        Nov 19 INCY Equity Markets Close Mixed Ahead of Nvidia Earnings
        Nov 19 INCY S&P 500 Gains and Losses Today: Supermicro Roars Back After Compliance Filing
        Nov 19 INCY Sector Update: Health Care Stocks Decline
        Nov 19 BMY Bristol-Myers Squibb Company (BMY) Jefferies London Healthcare Conference (Transcript)
        Nov 19 INCY Top Midday Decliners
        Nov 19 INCY Equities Mixed Intraday Amid Growing Russia-Ukraine Conflict
        Nov 19 INCY Incyte Pauses Enrollment in Chronic Spontaneous Urticaria Study
        Nov 19 INCY Incyte seesaws on report of potential Merck takeover interest
        Nov 19 INCY Incyte Stock Slumps After Firm Scraps Drug, Pauses Enrollment in Other Study
        Nov 19 INCY Incyte Is the S&P 500’s Worst Performer Today. What’s Hitting the Stock.
        Nov 19 INCY Incyte's $750 Million Escient Deal Faces Setback With Toxicology Issues In Two Investigational Drugs, Analyst Flags Challenges
        Nov 19 INCY Incyte Faces Challenges but Remains Focused on Strategic Growth
        Nov 19 INCY Incyte Collapses. Why Its $750 Million Escient Acquisition Now Looks Shattered.
        Nov 19 BMY Bristol Myers Squibb’s Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in Differentiated Research Platforms
        Nov 19 INCY Incyte sinks on setback for drugs acquired in $750M buyout
        Related Industries: Biotechnology Data Storage Drug Manufacturers - Major
        Related Stock Lists: Biopharmaceutical Kidney Disease Organ Systems Diabetes Heart Failure Inflammation Inflammatory Conditions Kidney Life Sciences Medicine Rheumatoid Arthritis S&P 500 Adult Stem Cell Alport Syndrome Antioxidant Atrial Fibrillation Autoimmune Disease Autosomal Dominant Polycystic Kidney Disease Back Pain Biopharmaceutical Products
        Diabetic Nephropathy

        Diabetic nephropathy is a type of kidney disease that is caused by damage to the blood vessels in the kidneys due to diabetes. It is a serious complication of diabetes and can lead to kidney failure. Symptoms of diabetic nephropathy include high blood pressure, swelling in the legs and feet, and protein in the urine. Treatment for diabetic nephropathy includes controlling blood sugar levels, taking medications to reduce blood pressure, and following a healthy diet.

        Browse All Tags